Labeler · US market

Antares Pharma, Inc.

Antares Pharma, Inc. is a US drug labeler with US FDA registrations covering 3 drug concepts (2 currently active) across 30 packages. It is currently the only active US supplier of 1 drug.

ACTIVE — US

openFDA · updated weekly

Labeler codes18657 · 54436

Active drugs2

Registrations4 active / 11

Packages30

Sole supplier of1 drugs

Portfolio3 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Testosterone Enanthate injection	rx	3	8	SUPPLYING
Hyaluronidase injection, solution	rx	1	1	SUPPLYING
Methotrexate injection, solution	rx	7	21	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Testosterone Enanthaterx

At a glance

TypeLabeler
Labeler codes18657, 54436
Filing names1
Drugs (active)2
Drugs (all time)3
US registrations11
Packages30

Recent events

Shortages, recalls, and registration changes across all filing names.

Sep 11, 2024
RECALLRecall (Class II): Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for an…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.